Posts in Government


Bankrupting Big Pharma Isn’t a Solution

Believe it or not, a recent op-ed in the Washington Post written by Robin Feldman took the position that pharmaceutical companies should charge prices for their drugs …
By Gene Quinn
2 months ago 0

Patent Owner Sues Former USPTO Officials for ‘Improperly Stacking the Deck’ Against Him

A patent owner has filed a lawsuit in the United States District Court for the Western District of Tennessee against former U.S. Patent and Trademark Office (…
By Eileen McDermott
2 months ago 8

MicroSurgical Decision Reiterates PTAB’s ‘Wide Net’ Approach to Transition Applications Under the AIA

March 16, 2013 marked a watershed date in the practice of patent law as the effective date of the Leahy-Smith America Invents Act (AIA). Per Section 3 of the AIA, …
By Katie Merriman
2 months ago 1

Curbing Cannabis Copycats: How to Protect Your Brand’s Reputation as Marijuana Companies Try to Make Their Mark

To capture attention in the crowded new field of cannabis-related goods and services, many companies are using other companies’ brands to promote their goods and services, including …

This Week in Washington IP: Protecting State Venue Choices in Big Tech Antitrust Lawsuits, Designing Accessible Digital Public Infrastructure, and Addressing Climate Change and Food Security with Oceanic Tech Developments

This week in Washington IP events, both houses of Congress are mainly quiet this week except for an executive business meeting hosted by the Senate Judiciary Committee …
By IPWatchdog
2 months ago 0

What is a ‘Patent Waiver’ Anyway? Zooming Out on the TRIPS COVID IP Waiver Debate

Scientists, engineers, and everyday people have developed solutions for testing, preventing, and treating the COVID-19 disease. Ordinarily, we wouldn’t think twice about granting patents on these …

Indigenizing the Intellectual Property System

On August 9, we once again observe the International Day of the World's Indigenous Peoples. Traditionally, international organizations take advantage of this time to promote the contributions of …

Humanizing Technology: Back to Basics on DABUS and AI as Inventors

With South Africa’s patent office having recently granted the first patent to an AI inventor, and an Australian court ruling in favor of AI inventorship, it’…
By Tomi Herold
2 months ago 20

PPAC Announcements: Hirshfeld Doubles Down on Director Review Authority; Commerce Department to File for Registration of USPTO Trademarks; Committee Requests Release of $64 Million in User Fees

During the Patent Public Advisory Committee (PPAC) quarterly meeting held today, participants provided an update on the Director Review process under the Supreme Court’s Arthrex v. …
By Eileen McDermott
2 months ago 9

Don’t Go Down the Rabbit Hole with the Foes of Bayh-Dole

Sensing an opening after the Biden Administration’s recent Executive Order put a hold on a pending regulation prohibiting the misuse of the march-in rights provision of …
By Joseph Allen
2 months ago 1

This Week in Washington IP: PPAC Quarterly Meeting, Pending Nominations Within the DOE’s Science Leadership, and Bills on Composite Technologies and Cybersecurity in U.S. Infrastructure

This week in Washington IP news, the House of Representatives remains quiet as it enters a scheduled district work period. However, several Senate committees will host hearings …
By IPWatchdog
2 months ago 0

Has Ex Parte Sauerberg Gutted the Patent Act’s Safe Harbor Provision?

This article concerns the impact of Ex Parte Sauerberg, a 2017 Patent Trial and Appeal Board (PTAB) decision, on the safe harbor provision of 35 U.S.C. § 121.  We …

Billionaire Space Race Between Bezos and Branson (and Musk) Pushes Forward Next Generation of Spaceflight Innovation

This July has been a landmark month for the commercial space sector thanks in large part to the determination of two tech billionaires: Richard Branson, business magnate …
By Steve Brachmann
2 months ago 0

A Closer, Evidence-Based Look at ‘Patent Quality’ Advocacy

The Patent Infringer Lobby has ramped up banging the drum about “patent quality.” They dedicated a week-long campaign to questioning "patent quality,” which its constituents regard as …
By James Edwards
2 months ago 17

Senate Judiciary Committee Advances Legislation to Reduce Drug Prices, Rein in Pharma Industry Practices

Earlier today, the Senate Judiciary Committee held an Executive Business Meeting in which the Committee discussed and favorably reported four bills aimed at reducing prescription drug prices …
By Eileen McDermott
2 months ago 2